Rikke Borg

2.7k total citations · 1 hit paper
32 papers, 1.7k citations indexed

About

Rikke Borg is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Nephrology. According to data from OpenAlex, Rikke Borg has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 8 papers in Nephrology. Recurrent topics in Rikke Borg's work include Diabetes Management and Research (16 papers), Diabetes Treatment and Management (12 papers) and Chronic Kidney Disease and Diabetes (7 papers). Rikke Borg is often cited by papers focused on Diabetes Management and Research (16 papers), Diabetes Treatment and Management (12 papers) and Chronic Kidney Disease and Diabetes (7 papers). Rikke Borg collaborates with scholars based in Denmark, Netherlands and United States. Rikke Borg's co-authors include J.C. Kuenen, Robert J. Heine, David M. Nathan, Hui Zheng, David Schoenfeld, Daniel R. Witte, Jørn Nerup, Frederik Persson, Dorte Vistisen and Hui Zheng and has published in prestigious journals such as Diabetes Care, Diabetes and Scientific Reports.

In The Last Decade

Rikke Borg

25 papers receiving 1.6k citations

Hit Papers

Translating the A1C Assay Into Estimated Average Glucose ... 2008 2026 2014 2020 2008 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rikke Borg Denmark 11 1.3k 422 332 255 155 32 1.7k
Priyathama Vellanki United States 20 1.1k 0.8× 409 1.0× 288 0.9× 150 0.6× 196 1.3× 73 1.5k
José León Spain 11 1.6k 1.2× 375 0.9× 530 1.6× 331 1.3× 188 1.2× 22 2.2k
J.C. Kuenen Netherlands 6 1.2k 0.9× 398 0.9× 305 0.9× 226 0.9× 137 0.9× 7 1.5k
Lorenzo Scappaticcio Italy 26 1.4k 1.1× 272 0.6× 465 1.4× 374 1.5× 158 1.0× 94 2.1k
Alanna Weisman Canada 16 666 0.5× 340 0.8× 407 1.2× 88 0.3× 136 0.9× 62 1.2k
Christopher A. Newton United States 21 1.3k 0.9× 459 1.1× 270 0.8× 211 0.8× 163 1.1× 30 1.6k
Sofia Dahlqvist Sweden 16 2.1k 1.5× 941 2.2× 1.0k 3.0× 263 1.0× 351 2.3× 25 2.6k
Felix Aberer Austria 19 624 0.5× 229 0.5× 261 0.8× 111 0.4× 99 0.6× 87 1.3k
Maddalena Trombetta Italy 20 785 0.6× 259 0.6× 384 1.2× 296 1.2× 255 1.6× 62 1.6k

Countries citing papers authored by Rikke Borg

Since Specialization
Citations

This map shows the geographic impact of Rikke Borg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rikke Borg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rikke Borg more than expected).

Fields of papers citing papers by Rikke Borg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rikke Borg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rikke Borg. The network helps show where Rikke Borg may publish in the future.

Co-authorship network of co-authors of Rikke Borg

This figure shows the co-authorship network connecting the top 25 collaborators of Rikke Borg. A scholar is included among the top collaborators of Rikke Borg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rikke Borg. Rikke Borg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Rodríguez, José, Rikke Borg, Edith Rodríguez-Braun, et al.. (2025). Clinical and immunopathological evaluation and its comparison with IHC consensus molecular subtypes of colorectal cancer. Scientific Reports. 15(1). 21626–21626.
2.
Lindhardt, Morten, et al.. (2025). Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study. BMC Primary Care. 26(1). 23–23. 1 indexed citations
3.
Palarasah, Yaseelan, Rikke Borg, Else‐Marie Bladbjerg, et al.. (2024). The contact system in chronic kidney disease and hemodialysis – A cross-sectional study. Thrombosis Research. 245. 109229–109229.
5.
Borg, Rikke, et al.. (2024). Hyperglycaemia in people with diabetes and chronic kidney disease. Ugeskrift for Læger. 186(20). 1–8. 1 indexed citations
7.
Borg, Rikke, Margit Kriegbaum, Mia Klinten Grand, et al.. (2023). Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death. BMC Primary Care. 24(1). 128–128. 10 indexed citations
8.
Persson, Frederik, Ditte Hansen, Iain Bressendorff, et al.. (2023). Design and methodology of the PRIMETIME 1 cohort study: PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathy. Clinical Kidney Journal. 16(12). 2482–2492. 3 indexed citations
9.
Borg, Rikke, Margit Kriegbaum, Christen Lykkegaard Andersen, & Frederik Persson. (2023). #2976 CHRONIC KIDNEY DISEASE WITH COMORBIDITY IN PRIMARY CARE: CARDIORENAL TREATMENT, QUALITY OF CARE AND PROGNOSIS. Nephrology Dialysis Transplantation. 38(Supplement_1). 1 indexed citations
10.
Borg, Rikke, Nicholas Carlson, Jens Søndergaard, & Frederik Persson. (2023). The Growing Challenge of Chronic Kidney Disease: An Overview of Current Knowledge. International Journal of Nephrology. 2023. 1–8. 38 indexed citations
11.
Kristensen, Jonas Henrik, Eva Greibe, Henrik Post Hansen, et al.. (2023). Plasma concentration of orally administered amoxicillin and clindamycin in patients receiving haemodialysis. Journal of Antimicrobial Chemotherapy. 78(3). 724–731. 2 indexed citations
12.
Feldt‐Rasmussen, Bo, Rikke Borg, Thomas Almdal, et al.. (2021). Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring. ˜The œNephron journals/Nephron journals. 146(2). 146–152. 10 indexed citations
13.
Persson, Frederik, Rikke Borg, & Peter Rossing. (2021). A narrative review of new treatment options for chronic kidney disease in type 2 diabetes. Annals of Translational Medicine. 9(8). 716–716. 8 indexed citations
14.
Idorn, Thomas, Filip K. Knop, Morten Buus Jørgensen, et al.. (2020). The Glycemic Effect of Liraglutide Evaluated by Continuous Glucose Monitoring in Persons with Type 2 Diabetes Receiving Dialysis. ˜The œNephron journals/Nephron journals. 145(1). 27–34. 13 indexed citations
15.
Færch, Kristine, Marjan Alssema, David J. Mela, Rikke Borg, & Dorte Vistisen. (2018). Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA 1c in individuals with and without diabetes. Nutrition and Diabetes. 8(1). 38–38. 31 indexed citations
16.
Borg, Rikke, Frederik Persson, Volkert Siersma, et al.. (2018). Interpretation of HbA1c in primary care and potential influence of anaemia and chronic kidney disease: an analysis from the Copenhagen Primary Care Laboratory (CopLab) Database. Diabetic Medicine. 35(12). 1700–1706. 19 indexed citations
17.
Borg, Rikke, Dorte Vistisen, Daniel R. Witte, & K. Borch‐Johnsen. (2010). Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1cThe Danish Inter99 study. Diabetic Medicine. 27(8). 906–910. 27 indexed citations
18.
Borg, Rikke, J.C. Kuenen, Bendix Carstensen, et al.. (2010). Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study. Diabetologia. 53(8). 1608–1611. 47 indexed citations
20.
Nathan, David M., et al.. (2009). The A1c-derived Average Glucose (ADAG) Study Group: Translating the A1C assay into estimated average glucose values (Diabetes Care (2008) 31(1473-1478)). Diabetes Care. 32(1). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026